Treatment of various diseases such as chemical ovarian Sindrome (PCOS), metabolic Sindrome, obesity, non-propane hepatitis (NASH), FGR1-bound antibodies, nucleic acid AI by using anti-fibroblast growth factor 1 (FGFR1) receptor wearer Slado, C Lula Huesped.
The disclosure provides FGFR1 agonists, including agonistic anti-FGFR1 antibodies, and methods of using the same.USO DE UN AGONISTA DEL RECEPTOR 1 DEL FACTOR DE CRECIMIENTO ANTI-FIBROBLASTOS (FGFR1) PARA TRATAR ENFERMEDADES TALES COMO SINDROME DE OVARIO POLIQUÍSTICO (PCOS), SINDROME METABÓLICO, OBESIDAD, ESTRATO HEPATITIS NO ALCOHÓLICA (NASH), ENTRE OTRAS; ANTICUERPO QUE SE UNE CON FGFR1; ACIDO NUCLEICO AISLADO; CÉLULA HUESPED.